Member access

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
03/04 | 09:20amPresentation
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Financials ( CHF)
Sales 2015 46 432 M
EBIT 2015 16 496 M
Net income 2015 11 304 M
Debt 2015 7 673 M
Yield 2015 3,17%
Sales 2016 48 481 M
EBIT 2016 17 663 M
Net income 2016 12 343 M
Debt 2016 3 788 M
Yield 2016 3,39%
PER 2015 19,91
PER 2016 18,33
EV / Sales 2015 5,00x
EV / Sales 2016 4,71x
Capitalization 224 546 M
More Financials
Latest news on ROCHE HOLDING LTD.
03/03 ROCHE : Global scientific collaborators to explore latest pathology and oncology..
02/25 Biosimilar copies of blockbuster drug launch in major EU markets
02/19DJROCHE : Gets FDA Priority Review for Cancer Treatment
02/13 Swiss private bank Notenstein to buy rival La Roche
02/09DJEUROPE MARKETS : Greek Jitters, Chinese Data Knock European Stocks Sharply Lower
02/09DJEUROPE MARKETS : Greek Jitters, Chinese Data Knock European Stocks Sharply Lower
02/06 ROCHE : FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Tre..
02/05 Pfizer to buy Hospira for $15 billion to bolster hospital products
More news
Sector news Pharmaceuticals - NEC
02:56p AKORN : Investors Encouraged to Contact Securities Law Firm about Investigation ..
02:46p Wall Street lower for second day; healthcare is sole gainer
02:32p JOHNSON & JOHNSON : Hillsborough OKs $2.1 million to bring Johnson & Johnson job..
Plus d'actualités du secteur Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF